SEC Form 4/A · accession 0001209191-15-047126
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
V Bryan Lawlis
Director
Period of report
Apr 1, 2015
Accepted (ET)
May 27, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $29.00 | Apr 1, 2015 | A | 20,000 | A | — | Mar 31, 2025 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F1 | $29.00 | Apr 1, 2015 | A | 6,250 | A | — | Mar 31, 2025 | Common Stock | 6,250 | 6,250 | D |
| Stock Option (Right to Buy)F2 | $29.00 | Apr 1, 2015 | A | 25,000 | A | — | Mar 31, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from April 1, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- F2Option granted to Reporting Person pursuant to his position as Chairman of the Scientific Advisory Board. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from April 1, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.